Literature DB >> 35867020

The impact of COVID-19 infection on patients with psoriasis treated with biologics: an Italian experience.

Angelo Ruggiero1, Fabrizio Martora1, Vincenzo Picone1, Luca Potestio1, Elisa Camela1, Teresa Battista1, Gabriella Fabbrocini1, Matteo Megna1.   

Abstract

Entities:  

Year:  2022        PMID: 35867020      PMCID: PMC9349949          DOI: 10.1111/ced.15336

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   4.481


× No keyword cloud information.
  2 in total

Review 1.  Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence.

Authors:  Angelo Ruggiero; Vincenzo Picone; Fabrizio Martora; Gabriella Fabbrocini; Matteo Megna
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-16

2.  Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics.

Authors:  Matteo Megna; Luca Potestio; Teresa Battista; Elisa Camela; Lucia Genco; Matteo Noto; Gabriella Fabbrocini; Fabrizio Martora
Journal:  Clin Exp Dermatol       Date:  2022-09-02       Impact factor: 4.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.